11/22/2017Sichuan Kelun Pharma Acquires 20% Stake of Competitor Shijiazhuang No....

11/22/2017PwC: Overseas Investments by Chinese Pharma Cos Up as Domestic M&A...

11/22/2017RiboBio and GE Healthcare Forges Partnership for Oligonucleotide Drug ...

11/21/2017Chengdu Kanghong Pharma to Acquire Israel's IOPtima

11/20/2017Acasti Pharma to License Its Hypertriglyceridemia Drug to Chinese Part...

11/19/2017Listed Chinese Pharma Cos Remain Major Advertisers in H1/2017

11/19/2017Domestically-listed Companies Maintains Growth in First 3Qs of 2017

11/16/2017Recent Official and Executive Moves

11/16/2017Shanghai Pharma Eyes Acquisitions in the U.S. and Europe Following Car...

11/15/2017Fujian-led Inter-provincial Drug Purchase Alliance Imminent

11/15/2017Update on Antitrust Legislative Development in China

11/15/2017Competition Impact Review to Be Required for All New Chinese Regulatio...

11/15/2017China Issues New Measure to Ensure Fair Competition

11/15/2017Is Walgreens Boots Alliance Pulling Out of Chinese JV Guangzhou Pharma

11/14/2017Reckitt Benckiser, Alibaba Join Hands to Market Quality Health Product...

11/14/2017Shanghai Pharma Buys Cardinal Health's China Business for $1.2B

11/13/2017XiAn Janssen Launches IMBRUVICA (ibrutinib) in China

11/13/2017Pfizer Divests from Chinese JV with Hisun

11/9/2017AstraZeneca Bets on Continued Growth in China as GSK Fades

11/9/2017Recent Executive Moves

11/9/2017SMEI: Chinese Drug Sales Growth Expected to Fall Further in 2017

11/8/2017Tsumura to Penetrate China's Herbal Drug Market with the Help of Ping ...

11/8/2017Biotest and Tiancheng Pharma to Rework Their Acquisition Deal after Na...

11/8/2017CBMG Opens New Facility and Joint Lab for Cell Therapy in Shanghai

11/8/2017Xynomic Licenses Global Rights of RAF Inhibitor from Boehringer Ingelh...

11/7/2017EddingPharm Spinoff Strives to Bring Potential Oncology Blockbusters t...

11/6/2017CFDA Accepts BMS's NDA for Optivo (Nivolumab)

11/6/2017SIMM Granted Clinical Trial Approval for New Alzheimer's Drug

11/6/2017Eisai Submits Chinese NDA for Hepatic Cancer Drug Lenvima

11/3/2017Fosun to Acquire the Ramaining 69.25% Stake in Taiwan-Based Henlix Bio...

Page:177/360 Total number of articles:10791: [First][<<] [175] [176] [177] [178] [179] [>>] [End]